September 30, 2011
A New Jersey federal judge on Friday rejected efforts by generic-drug maker Glenmark Pharmaceuticals Ltd. to overturn a jury's $16 million judgment against it for allegedly infringing a patent licensed exclusively to Abbott Laboratories for the blood pressure drug Tarka.